Sikhulile Moyo

Sikhulile Moyo
Born
Alma materUniversity of Zimbabwe
University of Botswana
Sefako Makgatho Health Sciences University
Stellenbosch University
Known forMoyo and his laboratory were the first to identify the SARS-CoV-2 Omicron variant
Children3
Scientific career
FieldsImmunology, infectious diseases
InstitutionsBotswana–Harvard AIDS Institute Partnership
Harvard T.H. Chan School of Public Health
ThesisHIV-1C Dynamics and Evolutionary Trends in Botswana
Doctoral advisorSusan Engelbrecht
Tulio de Oliveira

Sikhulile M. Moyo is a Zimbabwean virologist working as the laboratory director of the Botswana–Harvard AIDS Institute Partnership in Gaborone.[1][2] He is a research associate in immunology and infectious diseases at the Harvard T.H. Chan School of Public Health. In November 2021, Moyo and his laboratory were the first to identify the SARS-CoV-2 Omicron variant. In 2022, Moyo was listed in the Time 100 list.

  1. ^ Associated Press (December 4, 2021). "Scientist Says Omicron Was a Group Find". VOA. Retrieved 2021-12-18.
  2. ^ Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL, et al. (March 2022). "Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa". Nature. 603 (7902): 679–686. Bibcode:2022Natur.603..679V. doi:10.1038/s41586-022-04411-y. PMC 8942855. PMID 35042229.